Bicycle Therapeutics plc American Depositary Shares (BCYC)

Bicycle Toxin Conjugates (BTCs) are emerging as a novel targeted oncology technology, offering innovative peptide-based drug delivery with potential applications in cancer treatment and beyond, with early clinical trials showing promising results.

Here is how Bicycle Therapeutics PLC Sponsored ADR (BCYC) and Twist Bioscience (TWST) have performed compared to their sector so far this year.

During the last three months, 4 analysts shared their evaluations of Bicycle Therapeutics (NASDAQ:BCYC), revealing diverse outlooks from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somew...

The company said it is working with the FDA to structure a phase 2/3 trial for its bladder cancer therapy.